Description

DAFLON 1000 MG (1X20)

Indications

DAFLON 1000 MG is primarily indicated for the treatment of chronic venous insufficiency, which is characterized by symptoms such as leg pain, heaviness, swelling, and varicose veins. It is also used to manage acute hemorrhoidal episodes, providing relief from pain, bleeding, and discomfort associated with this condition. The formulation is designed to improve venous tone and microcirculation, thereby alleviating symptoms and improving the quality of life for affected patients.

Mechanism of Action

The active ingredients in DAFLON 1000 MG are micronized flavonoids, specifically diosmin and hesperidin. These compounds work synergistically to enhance venous tone and reduce venous distensibility. Diosmin, in particular, has been shown to increase lymphatic drainage and improve the microcirculation of blood vessels. This action helps to decrease venous stasis and promotes the return of blood to the heart. Additionally, DAFLON exhibits anti-inflammatory properties, which contribute to its effectiveness in treating hemorrhoidal symptoms by reducing inflammation and edema in the affected area.

Pharmacological Properties

DAFLON 1000 MG is classified as a venotonic and vasculoprotective agent. Its pharmacokinetics reveal that after oral administration, the active components are rapidly absorbed and distributed throughout the body. The peak plasma concentration occurs approximately 2 to 6 hours post-ingestion. The drug is primarily metabolized in the liver, with metabolites excreted mainly in the urine. The half-life of the active ingredients ranges from 11 to 12 hours, allowing for effective symptom control with the recommended dosage.

Contraindications

DAFLON 1000 MG is contraindicated in patients with known hypersensitivity to any of its components. Caution should be exercised when prescribing this medication to individuals with a history of allergic reactions to flavonoids or similar compounds. Additionally, it is not recommended for use in children due to a lack of established safety and efficacy in this population.

Side Effects

While DAFLON 1000 MG is generally well-tolerated, some patients may experience side effects. Common adverse reactions include gastrointestinal disturbances such as nausea, diarrhea, and abdominal pain. Rarely, patients may report allergic reactions, which can manifest as skin rashes or itching. In the event of severe side effects or signs of an allergic reaction, it is crucial to discontinue use and seek medical attention promptly.

Dosage and Administration

The recommended dosage of DAFLON 1000 MG varies depending on the condition being treated. For chronic venous insufficiency, the typical dosage is one tablet taken twice daily, preferably during meals. In cases of acute hemorrhoidal episodes, a higher dosage may be recommended, with two tablets taken three times daily for the first four days, followed by a reduced dosage of one tablet twice daily for the subsequent three days. It is essential to adhere to the prescribed dosage and consult a healthcare professional for any adjustments based on individual patient needs.

Interactions

DAFLON 1000 MG has not been shown to have significant drug interactions with other medications. However, patients should inform their healthcare provider about all medications they are currently taking, including over-the-counter drugs and herbal supplements. This information is crucial to avoid potential interactions that may affect the efficacy of DAFLON or lead to increased side effects.

Precautions

Before initiating treatment with DAFLON 1000 MG, it is important to conduct a thorough medical history and assessment of the patient. Special precautions should be taken in patients with severe liver or kidney impairment, as these conditions may affect drug metabolism and excretion. Additionally, patients with a history of gastrointestinal disorders should be monitored closely for any adverse effects. Pregnant or breastfeeding women should consult their healthcare provider before using this medication, as safety during pregnancy and lactation has not been fully established.

Clinical Studies

Numerous clinical studies have evaluated the efficacy and safety of DAFLON 1000 MG in various conditions. A randomized controlled trial demonstrated that patients with chronic venous insufficiency experienced significant improvements in symptoms such as leg pain and swelling after treatment with DAFLON compared to a placebo group. Another study focused on the management of acute hemorrhoidal episodes, showing that patients treated with DAFLON reported greater symptom relief and a faster resolution of discomfort compared to those receiving standard care. These studies support the clinical use of DAFLON 1000 MG as an effective treatment option for venous disorders and hemorrhoidal conditions.

Conclusion

DAFLON 1000 MG is a well-established medication for the management of chronic venous insufficiency and acute hemorrhoidal episodes. Its unique formulation of micronized flavonoids provides effective relief from symptoms while improving venous tone and microcirculation. With a favorable safety profile and a well-documented mechanism of action, DAFLON continues to be a valuable option in the treatment of venous disorders. Patients should always consult healthcare professionals for personalized advice and to ensure safe and effective use of this medication.